US 6407080
N-(pyrimidinyl)-aspartic acid analogs as interleukin-1&bgr; converting enzyme inhibitors
expired A61KA61K38/00A61P
Quick answer
US patent 6407080 (N-(pyrimidinyl)-aspartic acid analogs as interleukin-1&bgr; converting enzyme inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Jun 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jun 18 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K38/00, A61P, A61P29/00, A61P37/00